CSIMarket Company Name, Ticker, Suppliers, else..
 
Nuo Therapeutics Inc   (NUOT)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 48
 Employees 10
 Revenues (TTM) (Millions $) 4
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


Nuo Therapeutics Inc is a healthcare company based in Pennsylvania, USA. They specialize in developing and commercializing medical technologies for the treatment of chronic wounds. Their flagship product, Aurix System, is a biologic wound care therapy that uses the patient's blood to deliver healing factors directly to the wound site. Nuo Therapeutics aims to provide innovative solutions for patients suffering from debilitating chronic wounds, enhancing their quality of life and promoting faster healing.


   Company Address: 8285 El Rio, Suite 190 Houston 77054 TX
   Company Phone Number: 396-4770   Stock Exchange / Ticker: NUOT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ANIK   -0.29%    
ESTA   -2.54%    
IART   -5.29%    
MDXG        4.18% 
MMM   -2.45%    
SMTI        0.81% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.2
Working Capital Ratio 1.18
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.04 $
Revenues (TTM) 0.08 $
Cash Flow (TTM) 0 $
Cash 0.01 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 403,569
Net Income per Employee (TTM) -238,455
Receivable Turnover Ratio (TTM) 6.7
Inventory Turnover Ratio (TTM) 6.42
Asset Turnover Ratio (TTM) 2.28

Profitability Ratios Current
Gross Margin (MRQ) 65.26 %
Operating Margin (MRQ) -34.29 %
Net Margin (MRQ) -47.5 %
Net Cash Flow Margin (MRQ) -21.9 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Nuo Therapeutics Inc's Segments
Product    223.89 % of total Revenue
License    11.98 % of total Revenue
Aurix and Private Label Kits    212.44 % of total Revenue
Aurix and Private Label Centrifuge Devices    11.44 % of total Revenue
Single Reportable Segment    235.87 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.